Skip to main content

April 2020

 

Clinical courses

 

Clinical research courses

Faculty Recruitment in World College Of Pharmaceutical Sciences

WORLD COLLEGE OF PHARMACEUTICAL SCIENCES Girawar, Jhajjar-Sampla Road Jhajjar, Haryana.

Post :  Professor, Associate Professor, Assistant Professor

Vacancy for Junior Research Fellow at CSMCRI

CSMCRI with much scientific excitement has now achieved technological excellence with several granted patents in the core mandate of the institute and is one among the top performing national R&D laboratories in the country. At the beginning of 2011, the Institute has around 360 staff with 150 S&T staff on its roll and around 250 research fellows and project assistants pursing their doctoral programme.

Posts : Junior Research Fellow under JRF CSIR GATE scheme

Require Bioanalytical Manager at USP | Ph.D or M.Pharm, M.Sc

USP is proud to be an equal opportunity/affirmative action employer. Employment selection and related decisions are made without regard to sex, gender identity, race, age, disability, religion, national origin, color, veteran status or any other protected class. We are committed to working with and providing reasonable accommodation to individuals with disabilities

Post : Manager Bioanalytical

Vacancy for M.Pharm/B.Pharm with MBA as Project Manager at Abbott India Limited

Abbott India Limited is a subsidiary of Abbott Laboratories, USA, a global, iversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company now employs approximately 70,000 people and markets its products in 130 countries worldwide.

Post : Project Manager - Strategic Project Management

Job for Pharmacy graduates as Regional Sales Executive Manager at Abbott India Limited

Abbott India Limited is a subsidiary of Abbott Laboratories, USA, a global, iversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company now employs approximately 70,000 people and markets its products in 130 countries worldwide.

Post : Regional Sales Executive Manager

Require Clinical Data Reviewer at Bioclinica

Bioclinica is utilizing data and technology to enable more efficient trial conduct. We are looking at ways to reduce the size of the trials, provide greater clarity into the effect of the drug, and to reduce the amount of complexity in the trial. We do this by improving trial design and utilizing advanced analytics to identify patients who would be high responders for a particular clinical trial.

Post : Clinical Data Reviewer II

Hydroxychloroquine is taken under schedule H1 of Drugs and Cosmetics rules by central government to prevent  misuse and regulate sales of hydroxychloroquine. Hydroxychloroquine is anti-malarial medicine and known to have certain effects on novel corona virus infection (COVID-19) as per clinical trials.

The U.S. Food and Drug Administration has been providing unprecedented flexibility to labs and manufacturers to develop and offer COVID-19 tests across the U.S. The FDA’s regulations have not hindered or been a roadblock to the rollout of tests during this pandemic. Every action the FDA has taken during this public health emergency to address the COVID-19 pandemic has balanced the urgent need to make diagnostic tests available with providing a level of oversight that ensures accurate tests are being deployed.

EMA has implemented a new system to issue electronic certificates for human and veterinary medicines. As of today, the Agency will no longer provide printed certificates but only electronically signed and authenticated certificates to maintain EMA’s ability to provide these documents during the COVID-19 pandemic.

Supporting the rapid development and approval of effective and safe treatments for and vaccines against COVID-19 is EMA’s top priority to help save lives during the pandemic. Over recent weeks and months, the Agency has engaged with many developers of therapeutic medicines and there are a number of developments underway. However, at this point, on the basis of the preliminary data presented to the Agency, no medicine has yet demonstrated efficacy in treating COVID-19.